Topics

GSK reports 30% jump in first-quarter profits as demand for its vaccines booms

08:48 EDT 1 May 2019 | Proactive Investors

Revenue edged 6% higher in the quarter to £7.66bn, with almost all of that growth coming from the vaccines business

Original Article: GSK reports 30% jump in first-quarter profits as demand for its vaccines booms

NEXT ARTICLE

More From BioPortfolio on "GSK reports 30% jump in first-quarter profits as demand for its vaccines booms"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...